|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
EBSCO_ocn835671141 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130404s2012 nyu ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d OCLCF
|d YDXCP
|d OCLCQ
|d EBLCP
|d DEBSZ
|d OCLCQ
|d D6H
|d OCLCQ
|d VTS
|d TOF
|d STF
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 923653422
|
020 |
|
|
|a 9781619420151
|q (electronic bk.)
|
020 |
|
|
|a 1619420155
|q (electronic bk.)
|
020 |
|
|
|z 9781619420083
|
020 |
|
|
|z 1619420082
|
029 |
1 |
|
|a DEBBG
|b BV041049524
|
029 |
1 |
|
|a DEBBG
|b BV043775663
|
029 |
1 |
|
|a DEBSZ
|b 472781480
|
035 |
|
|
|a (OCoLC)835671141
|z (OCoLC)923653422
|
050 |
|
4 |
|a R850
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Advances in medicine & biology.
|n Volume 46 /
|c Leon V. Berhardt, editor.
|
260 |
|
|
|a Hauppauge, N.Y. :
|b Nova Science,
|c ©2012.
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Medicine and Biology ;
|v v. 46
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a ""ADVANCES IN MEDICINE AND BIOLOGY VOLUME 46 ""; ""ADVANCES IN MEDICINE AND BIOLOGY VOLUME 46 ""; ""CONTENTS ""; ""PREFACE ""; ""SEXUAL DIMORPHISM IN CORTICOSTEROID SIGNALING � UNDERNEATH VULNERABILITY TO STRESS-RELATED DISORDERS AND SENSITIVITY TO ANTIDEPRESSANTS ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""HOW DOES CORTICOSTEROID RECEPTORS PROTEIN LEVEL DIFFER BETWEEN GENDERS? ""; ""Influence of Stress ""; ""Response to Antidepressant Drugs ""; ""THE IMPORTANCE OF THE CORTICOSTEROID RECEPTOR HORMONE-BINDING CAPACITY � UNDER THE SPOTLIGHT ""; ""The MR/GR Ratio ""; ""The Binding Potency ""
|
505 |
8 |
|
|a ""DO ANTIDEPRESSANTS COOPERATE WITH THE RECEPTOR�S CHAPERONES? """"THE RECEPTOR�S BINDING TO THE NUCLEI AND DNA ""; ""GENDER DIFFERENCES IN THE ANTIDEPRESSANT DRUG METABOLISM""; ""OTHER MECHANISMS CONTRIBUTING TO SEXUALLY DIMORPHIC RESPONSE TO STRESS AND TO ANTIDEPRESSANT DRUGS ""; ""The Hormone Availability ""; ""Transport through Membrane ""; ""CONCLUDING REMARKS AND FUTURE PERSPECTIVES""; ""REFERENCES ""; ""CELL MATRIX INTERACTIONS AND ROLE OF INTEGRINS IN LIVER DEVELOPMENT ""; ""INTRODUCTION ""; ""1. FOCAL ADHESIONS ""; ""1.1. Composition of Focal Adhesions ""
|
505 |
8 |
|
|a ""1.1.1. Tyrosine Phosphorylation at Focal Adhesions""""1.1.2. Adaptor Proteins/ Binding Proteins ""; ""1.2. Regulation of Focal Adhesions ""; ""2. LIVER DEVELOPMENT ""; ""2.1. Hepatic Endoderm Specification ""; ""2.2. Formation of the Hepatic Bud `from Hepatic Endoderm ""; ""2.2.1. Proliferation and Migration ""; ""2.2.2. Liver Bud Growth ""; ""2.3. Hepatocyte Specification ""; ""2.4. Hepatocyte Maturation ""; ""3. LIVER ARCHITECTURE ""; ""4. DISRUPTED LIVER ARCHITECTURE ""; ""4.1. Fibrosis""; ""4.2. Integrins and Liver Disease""; ""CONCLUSIONS ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES ""
|
505 |
8 |
|
|a ""HEPATIC ENCEPHALOPATHY """"ABSTRACT ""; ""INTRODUCTION ""; ""CLINICAL DEFINITION OF HE ""; ""CLINICAL SCALES FOR HE GRADING ""; ""A) Scaling System ""; ""B) Neuropsychometric Tests ""; ""C) Critical Flicker Frequency (CFF) Test [13, 14] ""; ""PROGNOSIS OF HE""; ""PATHOGENESIS""; ""AMMONIA AND ITS METABOLITES ""; ""ROLE OF GLUTAMINE ""; ""MANGANESE ""; ""GABA HYPOTHESIS ""; ""NEUROSTEROIDS ""; ""INFLAMMATION ""; ""OXIDATIVE STRESS ""; ""TREATMENT ""; ""1. Nutritional Management ""; ""Branched-Chain Amino Acids ""; ""Implementation ""; ""Acute Encephalopathy ""
|
505 |
8 |
|
|a ""2. Reduction in the Nitrogenous Load Arising From the Gut """"A) Bowel Cleansing ""; ""Implementation ""; ""B) Nonabsorbable Disaccharides ""; ""Implementation ""; ""C) Antibiotics ""; ""Implementation ""; ""D) Acceleration of Urea Cycle ""; ""3. Drugs that Affect Neurotransmission ""; ""A) Dopaminergic System""; ""B) GABA-benzodiazepine System ""; ""Implementation ""; ""CONCLUSION ""; ""REFERENCES ""; ""BASIC GUIDELINES FOR THE COLLECTION AND SUBMISSION OF NECROPSY SAMPLES ""; ""ABSTRACT ""; ""INTRODUCTION""; ""EQUIPMENT ""; ""SAFETY PRECAUTIONS ""; ""NECROPSY REQUISITION FORM ""
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Clinical medicine.
|
650 |
|
0 |
|a Biology.
|
650 |
|
2 |
|a Clinical Medicine
|
650 |
|
2 |
|a Biology
|
650 |
|
6 |
|a Médecine clinique.
|
650 |
|
6 |
|a Biologie.
|
650 |
|
7 |
|a biology.
|2 aat
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Biology.
|2 fast
|0 (OCoLC)fst00832383
|
650 |
|
7 |
|a Clinical medicine.
|2 fast
|0 (OCoLC)fst00864361
|
700 |
1 |
|
|a Berhardt, Leon V.
|
776 |
0 |
8 |
|i Print version:
|t Advances in medicine & biology. Volume 46.
|d Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012
|z 9781619420083
|w (OCoLC)775029465
|
830 |
|
0 |
|a Advances in Medicine and Biology.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535083
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3017804
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10654775
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 535083
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7239263
|
994 |
|
|
|a 92
|b IZTAP
|